reported that tirzepatide treatment was associated with lower risk of all-cause mortality, adverse cardiovascular events, acute kidney injury, and adverse kidney events compared to GLP-1 RAs in patients with T2D [43]
Avoid processed foods, sugary snacks, and excessive carbohydrates
After removing duplicates, 210 unique articles remained for screening
TrimRx operates entirely online with no in-person visit requirement
February 6, 2026: Newer, Potentially Stronger Weight Loss Injections May Outperform Zepbound At least two new GLP-1 drugs may enter the market soon, and their manufacturers claim they can help patients lose up to twice as much weight compared to Zepbound and other weight loss drugs
Semaglutide users should pay particular attention to B12 status, since studies specifically examining semaglutide have shown impaired B12 absorption